2025
-
SABCS Snippets: Lobular Breast Cancer
Rahul Gosain, MD, of the Oncology Brothers, talks with Marleen Kok, MD, PhD, about how lobular carcinoma — which comprises 10-15% of all invasive breast cancers — differs from ductal carcinoma.
-
SABCS Snippets: Obesity and Breast Cancer Risk
Rohit Gosain, MD, of the Oncology Brothers, talks with Kristy Brown, PhD, about the biological link between obesity and risk of breast cancer.
-
SABCS Snippets: Beyond CDK4/6 Inhibitors
SABCS Program Director Kate Lathrop, MD, talks with Shom Goel, MBBS, PhD, about CDK4/6 inhibitors and emerging options to advance treatment for HR-positive, HER-negative metastatic breast cancer.
-
SABCS Snippets: Breast Cancer in Younger Patients
Rahul Gosain, MD, of the Oncology Brothers, talks with Virginia Borges, MD, about the increasing number of women under the age of 50 receiving a breast cancer diagnosis.
-
SABCS Snippets: Next Generation Endocrine Therapy
Rahul Gosain, MD, of the Oncology Brothers, talks with Mafalda Oliveira, MD, PhD, about the emerging class of drugs — including oral SERDs and PROTAC estrogen receptor degraders — and whether they are working better for patients.
-
Back-to-back sessions to illuminate ADC complexities, considerations for clinical use
Adrienne G. Waks, MD, will moderate one of two Wednesday afternoon sessions exploring the leading edge of ADC research, including biomarker implications, mechanisms of action, and considerations for the use of ADCs in clinical practice.
-
SABCS Schedule Spotlight for Wednesday, December 10
Plan your Wednesday schedule and don’t miss notable items on the program, including the first General Session, the first Poster Spotlight sessions, and more.
-
State of the Art session to explore how liquid biopsy can guide adaptive therapy
François-Clément Bidard, MD, PhD, will present on Wednesday afternoon about how liquid biopsy can optimize risk assessment and personalize treatment approaches in breast cancer.
-
State of the Art session to shed light on role of non-T cells in modulating TME, anti-tumor responses
Christos Sotiriou, MD, PhD, will moderate a Thursday afternoon session focused on the current understanding of the role of non-T cells in the tumor microenvironment (TME).
-
Welcome to SABCS 2025: Greetings from the symposium co-directors
San Antonio Breast Cancer Symposium co-directors, Carlos Arteaga, MD, and Virginia Kaklamani, MD, are honored to welcome attendees to the preeminent international scientific meeting for breast cancer research.